Colorectal Cancer Screening and Surveillance

Researchers are invited to submit abstracts for the "Colorectal Cancer Screening and Surveillance" track at GASTROENTEROLOGY-2024. This track will focus on advancements in screening methodologies, surveillance strategies, and diagnostic technologies aimed at improving early detection and management of colorectal cancer.

Abstract submissions should address innovative approaches in colorectal cancer screening, including fecal occult blood tests (FOBT), colonoscopy advancements, virtual colonoscopy (CT colonography), and emerging biomarkers for early detection. We encourage submissions on surveillance protocols post-polypectomy, interval cancer rates, and quality indicators in screening programs.

What to Expect:

Attendees can expect insightful sessions featuring expert presentations on the latest research findings, clinical trials, and guidelines in colorectal cancer screening and surveillance. The track will explore the role of artificial intelligence in imaging interpretation, patient adherence to screening protocols, and population-based strategies to reduce disparities in screening rates.

Join us at GASTROENTEROLOGY-2024 to engage in discussions that shape the future of colorectal cancer prevention and early detection. Collaborate with leaders in the field, exchange ideas, and contribute to advancing evidence-based practices in colorectal cancer screening and surveillance.

    Related Conference of Colorectal Cancer Screening and Surveillance

    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE
    March 10-11, 2025

    8th International Congress on Viral Hepatitis

    Paris, France
    March 13-14, 2025

    13th International Conference on Gynecology and Obstetrics

    Prague, Czech Republic
    August 21-22, 2025

    6th Global Summit on Earth Science and Climate Change

    Aix-en-Provence, France

    Colorectal Cancer Screening and Surveillance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in